Mesoblast Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Mesoblast Ltd with three other
companies in this sector in Australia:
sales of 18.57 million Australian Dollars [US$14.26 million]
of which 80%
was Bronchitol and Aridol),
Tempo Australia Limited
(81.37 million Australian Dollars [US$62.50 million]
Xrf Scientific Ltd
(21.13 million Australian Dollars [US$16.23 million]
of which 43%
was Precious Metals).
During the year ended June of 2016, sales at
Mesoblast Ltd were A$58.52 million (US$44.95 million).
increase of 146.4%
versus 2015, when the company's sales were A$23.75 million.